WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a medical device company and a leader in cardiac surgical ablation systems, today reported third quarter 2008 revenues of $14.8 million for its seasonally light third quarter and record revenues from domestic minimally invasive products of $5.7 million, an increase of 62.5% over the third quarter of 2007. Loss per share improved 33.3% to $0.12 for the third quarter of 2008.
